Your browser doesn't support javascript.
loading
A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo.
Ni, Yan G; Di Marco, Stefania; Condra, Jon H; Peterson, Laurence B; Wang, Weirong; Wang, Fubao; Pandit, Shilpa; Hammond, Holly A; Rosa, Ray; Cummings, Richard T; Wood, Dana D; Liu, Xiaomei; Bottomley, Matthew J; Shen, Xun; Cubbon, Rose M; Wang, Sheng-ping; Johns, Douglas G; Volpari, Cinzia; Hamuro, Lora; Chin, Jayne; Huang, Lingyi; Zhao, Jing Zhang; Vitelli, Salvatore; Haytko, Peter; Wisniewski, Douglas; Mitnaul, Lyndon J; Sparrow, Carl P; Hubbard, Brian; Carfí, Andrea; Sitlani, Ayesha.
Affiliation
  • Ni YG; Department of Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey, USA. yan_ni@merck.com
J Lipid Res ; 52(1): 78-86, 2011 Jan.
Article in En | MEDLINE | ID: mdl-20959675
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Fab Fragments / Receptors, LDL / Serine Endopeptidases / Cholesterol, LDL Limits: Animals / Humans / Male Language: En Journal: J Lipid Res Year: 2011 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Fab Fragments / Receptors, LDL / Serine Endopeptidases / Cholesterol, LDL Limits: Animals / Humans / Male Language: En Journal: J Lipid Res Year: 2011 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos